India vs Nepal: Cause of death, by non-communicable diseases, ages 15-59, female
India
52.6%
in 2021
Nepal
53.3%
in 2021
India rank
123rd
Nepal rank
121st
Cause of death, by non-communicable diseases, ages 15-59, female over time
- India
- Nepal
How they compare
Nepal currently reports 53.3% against 52.6% in India, a difference of 0.7%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Nepal ahead.
India ranks 123rd and Nepal ranks 121st of 185 countries.
Across the 3 decades both report, India averaged higher in 2 and Nepal in 1.
Head to head by decade
| Decade | India | Nepal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.3% | 41.3% | 1.0% | Nepal |
| 2010s | 59.4% | 53.2% | 6.1% | India |
| 2020s | 57.3% | 55.1% | 2.1% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, female, India or Nepal?
- Nepal, at 53.3% against 52.6% in India as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, female between India and Nepal?
- 0.7%, with Nepal ahead.
- How many years of comparable data are there for India and Nepal?
- 6 years are reported by both, from 2000 to 2021.
- How do India and Nepal rank globally for cause of death, by non-communicable diseases, ages 15-59, female?
- India ranks 123rd and Nepal ranks 121st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, female (% of total female deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 15-59 due to non-communicable diseases divided by number of all female deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.